Roberta D'Arrigo
机构: Dirigente I Fascia, INMI L. Spallanzani Roma
每年引用次数
引用次数
引用: 1,860
H-指数: 27
I10-指数 : 39
出版物: 85
Involvement of New Mutational Pattern in HIV-1 gp41 in T-20 Treatment
S AQUARO , V SVICHER , R DARRIGO , M SANTORO
Antiviral Research 74 ( 3)
2007
BP 67—76130 MONT SAINT AIGNAN (France).
O SCHWEBEL , G GOUESBET , JN LETOULOUZAN , R DARRIGO
High Sequence Conservation of Human Immunodeficiency Virus Type 1 Reverse Transcriptase under Drug Pressure despite the Continuous Appearance of Mutations
Francesca Ceccherini-Silberstein , Federico Gago , Maria Santoro , Caterina Gori
Journal of Virology 79 ( 16) 10718 -10729
57
2005
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure.
Francesca Ceccherini-Silberstein , Fulvio Erba , Federico Gago , Ada Bertoli
AIDS 18 ( 12) 11 -19
62
2004
Antigenic hiv-1 peptides
Francesco Dieli , Jacques Simpore , Giulia Cappelli , Thomas Toni
2005
Dynamics of NRTI resistance mutations during therapy interruption.
Maria Trignetti , Tobias Sing , Valentina Svicher , Maria Mercedes Santoro
AIDS Research and Human Retroviruses 25 ( 1) 57 -64
12
2009
Characterization and structural analysis of HIV-1 integrase conservation
Francesca Ceccherini-Silberstein , Isabelle Malet , Roberta D'Arrigo , Andrea Antinori
Aids Reviews 11 ( 1) 17 -29
127
2009
Human immunodeficiency virus type 1 intersubtype recombinants predominate in the AIDS epidemic in Cameroon.
Roberta D'Arrigo , Fouda Pierre Joseph , Innocent Ngong , Judith N. Torimiro
New Microbiologica 32 ( 4) 325 -331
13
2009
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group.
Gioacchino Angarano , Antonio Di Biagio , Gaetana Sterrantino , Laura Monno
New Microbiologica 33 ( 3) 195 -206
46
2010
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group.
Roberto Cauda , Gioacchino Angarano , Antonio Di Biagio , Gaetana Sterrantino
New Microbiologica 35 ( 1) 17 -25
27
2012
Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy
Maria Concetta Bellocchi , Pasquale Narciso , Valerio Tozzi , Mauro Zaccarelli
New Microbiologica 29 ( 2) 89 -100
5
2006
The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.
Evangelo Boumis , Maria Concetta Bellocchi , Pasquale Narciso , Patrizia Lorenzini
Antiviral Therapy 8 ( 6) 611 -616
11
2003
Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.
Simona Di Giambenedetto , Patrizio De Longis , Maria Concetta Bellocchi , Valerio Tozzi
Antiviral Therapy 8 ( 1) 51 -56
28
2003
Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/μl
Cristina Mussini , Roberto Bugarini , Carlo Federico Perno , Andrea Antinori
AIDS 16 ( 11) 1551 -1554
18
2002
Selected amino acid mutations in HIV-1 B subtype gp41 are Associated with Specific gp120V3 signatures in the regulation of Co-Receptor usage
Salvatore Dimonte , Fabio Mercurio , Valentina Svicher , Roberta D'Arrigo
Retrovirology 8 ( 1) 33 -33
42
2011
Comparative Analysis of Drug Resistance Among B and the Most Prevalent Non-B HIV Type 1 Subtypes (C, F, and CRF02_AG) in Italy
Maria Mercedes Santoro , Claudia Alteri , Luigi Ronga , Philippe Flandre
AIDS Research and Human Retroviruses 28 ( 10) 1285 -1293
14
2012
Molecular Epidemiology of HIV Type 1 CRF02_AG in Cameroon and African Patients Living in Italy
Nazle Mendonca Collaço Véras , Maria Mercedes Santoro , Rebecca R. Gray , Andrew J. Tatem
AIDS Research and Human Retroviruses 27 ( 11) 1173 -1182
18
2011
Reliability and Clinical Relevance of the HIV-1 Drug Resistance Test in Patients With Low Viremia Levels
Maria Mercedes Santoro , Lavinia Fabeni , Daniele Armenia , Claudia Alteri
Clinical Infectious Diseases 58 ( 8) 1156 -1164
50
2014
Potential implications of CYP3A4, CYP3A5 and MDR-1 genetic variants on the efficacy of Lopinavir/Ritonavir (LPV/r) monotherapy in HIV-1 patients.
Giulia Berno , Mauro Zaccarelli , Caterina Gori , Massimo Tempestilli
Journal of the International AIDS Society 17 ( 4) 19589 -19589
5
2014
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs
Claudia Alteri , Valentina Svicher , Caterina Gori , Roberta D'Arrigo
BMC Infectious Diseases 9 ( 1) 111 -111
29
2009